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Abstract: Coats’ disease diagnosed in adulthood is rare; therefore, the treatment options and 
longer clinical course are not well established. We report on two cases of adult onset Coats’ 
disease, which have been observed for more than 10 years after conventional treatment. In the 
first case, a 76-year-old man with 9 years of diabetic retinopathy noticed a visual field defect 
in his left eye. Yellowish subretinal exudation with serous retinal detachment in his superior 
peripheral retina, and telangiectatic vessels with fluorescein leakage, numerous microaneurysms, 
and areas of capillary nonperfusion observed in a fluorescein angiography indicated adult 
Coats’ disease, and retinal photocoagulation was applied. Within 1 year, subretinal exudation 
was regressed and visual acuity was improved from 20/50 to 20/20, and was maintained for 
the next 11 years. In the second case, a 71-year-old man presented with decreased vision in 
his right eye. The fundus of his right eye showed multiple telangiectasic vessels and subretinal 
exudates extended to the fovea, which is diagnosed as adult Coats’ disease. Despite retinal 
photocoagulation, an increase of exudation and an enlargement of retinal detachment was 
observed within 1 month, and subsequently, additional treatment of cryotherapy was performed. 
Two months after these therapies, the exudation was regressed without retinal detachment, and 
visual acuity was improved to 20/200 which was maintained for the next 10 years. Even with 
adult Coats’ disease, conventional therapies of retinal photocoagulation and cryotherapy are 
effective and are the initial choice for improving or maintaining visual function.
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Introduction
Coats’ disease was first described by George Coats in 1908,1 and is characterized by 
the formation of telangiectatic and aneurismal changes of the retinal vessels and is 
associated with a large amount of yellowish intraretinal and subretinal exudates.2 It is 
predominantly unilateral occurring mostly in young males under the age of 5 years, 
and can cause severe visual loss resulting from exudative retinal detachment.3
Less commonly, Coats’ disease presents in adulthood. The mean age at the time 
of diagnosis is approximately 50 years, and it progresses at a slower rate, but with 
similar features.4 Although various methods have been employed to treat Coats’ disease, 
including diathermy, retinal photocoagulation, cryotherapy, and vitreous surgery to 
elucidate the abnormal vessels, thereby minimizing exudation, the prognosis of visual 
function remains unsatisfactory.5 However, only a few cases of the clinical course of 
adult Coats’ disease after treatment have been reported.
In this article, we report the long-term follow-up of two cases of rapidly progressive 
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lipid exudates close to the macular area. In these cases 
successful treatment with conventional therapy of retinal 
photocoagulation and/or cryoretinopexy improved Coats’ 
disease and allowed the patients to keep their visual function 
for more than 10 years.
Case 1
A 76-year-old man noticed a visual field defect and 
decreased vision of 20/50 in his left eye. He had a history 
of diabetic retinopathy diagnosed 9 years before (at age of 
67) and focal retinal photocoagulation had been applied 
and observed every year without any visual disturbance. 
At the initial visit (Figure 1A), fundus examination revealed 
thick subretinal exudates extended to and threatening 
the fovea, and fluorescein angiography (FA) showed 
telangiectatic vessels with fluorescein leakage, numerous 
microaneurysms, and areas of capillary nonperfusion. An 
optical coherence tomography (OCT) indicated an exudative 
retinal detachment, which is a hallmark of advanced Coats’ 
disease.6 He was diagnosed as having Coats’ disease at 
age 76. Laser photocoagulation was applied to the vascular 
lesion, and then subretinal exudates were gradually regressed. 
At 1 year after the treatment, visual acuity improved to 20/20, 
and abnormal retinal vessels and subretinal exudates were 
significantly regressed. FA indicated marked reduction of 
fluorescein leakage from abnormal retinal vessels compared 
to the previous status, and OCT presented a disappearance 
of exudative retinal detachment (Figure 1B).
At a follow-up 11 years after the treatment for Coats’ 
disease, subretinal exudation was minimized with retinal 
atrophy and visual acuity in his left eye remained at 20/20 
(Figure 1C).
Case 2
A 71-year-old man was referred to our hospital due to visual 
impairment in his right eye despite successful cataract 
surgery. He noticed visual disturbance 3 years before the 
surgery. At his initial visit, the best-corrected visual acuity of 
his right eye was 12/20 and the fundus examination and FA 
revealed severe lipid exudation and multiple telangiectatic   
vessels found on the overall retina with exudative retinal 
detachment (Figure 2A). A clinical diagnosis of Coats’ 
disease was made and laser photocoagulation was applied 
to all telangiectatic vessels. However, it was difficult to 
inhibit aggravation of the disease condition, and visual acuity 
worsened to 8/200. Thus, additional treatment of cryotherapy 
Figure 1 Color fundus photograph (upper panel), corresponding fluorescein angiography (middle), and optical coherence tomography (lower) of the left eye in patient #1 
with adult Coats’ disease: (A) at the initial visit; (B) 1 year after treatment of retinal photocoagulation; (C) 11 years after treatment.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Clinical course of adult Coats’ disease
was performed 1 month after the photocoagulation. Three 
months after that, lipid exudation was settled with the 
disappearance of exudative detachment, and visual acuity 
improved to 20/200 (Figure 2B). At a follow-up 10 years 
after the treatment, subretinal exudation was diminished and 
the right VA remained at 20/200 (Figure 2C).
Comments
According to several studies,2–7 the progression of Coats’ 
  disease is relatively slow in older children or adults, and 
it shows indolent clinical features. The adult cases are 
often asymptomatic and the extent of exudation and reti-
nal detachment tends to be mild and limited; however, the 
involvement of the macula as a result of subretinal exudates 
or exudative retinal detachment can produce poor visual 
acuity. Although diabetes mellitus was associated with 
case #1, clinical features and clinical course were typical 
Coats’ disease. Visual prognosis in the long timespan of the 
  follow-up (more than 10 years) showed poor results including 
visual acuity change from 20/40 to 4/200 over 15 years, and 
20/30 to 20/70 over 11 years.4
Although clinical treatments for adult onset Coats’ 
disease are not well established due to the low number 
of cases, ablation of abnormal retinal vessels either by 
laser photocoagulation or by cryotherapy are adopted in 
clinical situations. In this case report, intensive therapy of 
photocoagulation and cryoretinopexy to vascular lesions was 
effective enough to reduce or remove the exudative changes, 
and more importantly, have suppressed the worsening or 
recurrence of exudation for more than 10 years. Thus, these 
therapies were able to either improve or stabilize vision in 
both cases. Laser photocoagulation in the early stages, either 
alone, or in combination with cryotherapy, has proven to 
be effective especially in cases of the young. In case #1, 
prompt photocoagulation after decreased vision, similar to 
treatment in Coats’ disease of the young, resulted in a good 
visual prognosis for a long time, which indicated that prompt 
treatment and careful follow-up in adult-onset Coats’ disease 
are crucial for the preservation of visual function. Even in 
case #2, although conventional therapies were effective for 
inhibition of worsening visual function, final visual acuity 
of 20/200 was not satisfactory, and earlier treatment before 
vision deteriorates might lead to better visual prognosis. In 
addition, more powerful treatment options such as recently 
successful treatments using a combination therapy of 
photodynamic therapy (PDT) and intravitreal bevacizumab 
injection (IVB) for severe adult Coats’ disease have been 
reported for a better visual prognosis.8 Unfortunately, both 
PDT and IVB were not available in 1997, but in the future, 
such a treatment option may help patients similar to those 
in case #2.
In conclusion, we have presented two cases of rapidly 
progressive adult onset Coats’ disease with exudative retinal 
detachment and massive and/or extensive lipid exudates. 
For these cases, conventional therapies were confirmed as 
effective and useful treatments to maintain visual function 
Figure 2 Color fundus photograph (upper panel), corresponding fluorescein angiography (lower) of the right eye in patient #2 with adult Coats’ disease. (A) At the initial 
visit; (B) 3 months after treatment of retinal photocoagulation and cryotherapy; (C) 10 years after treatment (FA image not available).Clinical Ophthalmology
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not only for the short term but also for longer clinical courses 
of more than 10 years.
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